Clinical Trials

32 enrolled

Breast Neoplasms

NCT04265872 2026-02-12

Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC

Breast Neoplasms

NCT04016818 2026-02-10

Pilot Breast-Dedicated PET Camera With 1 Millimeter Spatial Resolution

Breast Neoplasms

NCT03387553 2026-02-09

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

31 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT05333874 2026-02-09

CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage

34 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07236177 2026-02-05

B-GLUCANCER2

BreastGastrointestinalThoracic

220 enrolled

Breast Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

NCT04044872 2026-02-02

Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity

Phase EARLY_PHASE1 Terminated

3 enrolled

Unilateral Breast Neoplasms, Cardiotoxicity

NCT01881048 2026-01-29

Window of Opportunity Study Targeting the Inflammatory Milieu

42 enrolled

Breast Neoplasms

NCT06435351 2026-01-29

Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy

16 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06828588 2026-01-29

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

30 enrolled

BreastGastrointestinal

Esophageal Squamous Cell Carcinoma, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Stomach Neoplasms

NCT03321045 2026-01-26

Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness

10 enrolled

Breast Neoplasms

NCT05921253 2026-01-26

OU-SCC-NCAN

104 enrolled

BreastLymphoid

Breast Neoplasms, Lymphoma

NCT06499090 2026-01-22

Mirtazapine for Acute and Chronic Post Mastectomy Pain

62 enrolled

Breast Neoplasms

NCT06220214 2026-01-15

Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer

30 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07340424 2026-01-14

A Prospective, Open-label, Single-arm, Exploratory Clinical Trial to Evaluate the Safety and Tolerability of 225Ac-TR2205 Injection in Patients With Triple-negative Breast Cancer.

15 enrolled

Advanced Metastatic Triple-negative Breast Cancer (mTNBC)

NCT06645808 2025-12-29

VARTUTRACE

BreastCNSGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

32 enrolled

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Chondrosarcoma, Colonic Neoplasms, Esophageal Neoplasms, Glioblastoma, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Sarcoma, Osteosarcoma, Stomach Neoplasms

NCT05704283 2025-12-26

3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer

55 enrolled

Breast Neoplasms

NCT04174352 2025-12-22

FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer

12 enrolled

ERα+ Breast Cancer

NCT06274034 2025-12-16

MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors

40 enrolled

Breast Neoplasms

NCT05142475 2025-12-11

A Study of GC101 TIL in Advanced Breast Cancer (10hospital)

50 enrolled

Phase EARLY_PHASE1 Withdrawn

Breast Neoplasms

NCT05957042 2025-12-10

Pilot Study to Evaluate if Contrast Enhanced Ultrasound (CEUS) Can Predict Treatment Response in Triple Negative Breast Cancer (TNBC) Patients Receiving Combined Chemotherapy and Immune Checkpoint Inhibitors (ICI).

Breast Neoplasms

NCT04821375 2025-10-29

Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers

16 enrolled

Breast Neoplasms

NCT02744053 2025-10-20

DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer

96 enrolled

Phase EARLY_PHASE1 Terminated

Triple Negative Breast Neoplasms

NCT04712721 2025-10-10

Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.

14 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Glioblastoma

NCT05754749 2025-09-25

Comparison of CE-DBT and MRI in Patients With Known Breast Lesions

Breast Neoplasms

NCT03802604 2025-09-09

PROMETEO

28 enrolled

Breast Neoplasms

NCT04147494 2025-08-12

Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues

BreastGastrointestinalGenitourinaryGynecologicThoracic

29 enrolled

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT06273852 2025-08-11

A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors

8 enrolled

BreastHead & Neck

Squamous Cell Carcinoma of Head and Neck, Triple Negative Breast Neoplasms

NCT06700070 2025-08-11

A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors

12 enrolled

BreastHead & Neck

Squamous Cell Carcinoma of Head and Neck, Triple Negative Breast Neoplasms

NCT05859971 2025-07-29

ICG and SLN Mapping

10 enrolled 7 charts

Phase EARLY_PHASE1 Withdrawn

Breast Neoplasms

NCT06246786 2025-07-16

Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)

Triple Negative Breast Neoplasms

NCT06411678 2025-06-17

Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer

50 enrolled

Phase EARLY_PHASE1 Enrolling by invitation

Breast Neoplasms

NCT07023848 2025-06-17

PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors

10 enrolled

BreastGastrointestinalGenitourinary

Breast Neoplasms, Carcinoma, Transitional Cell, Stomach Neoplasms

NCT07023861 2025-06-17

The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies

Phase EARLY_PHASE1 Enrolling by invitation

BreastGastrointestinalGenitourinary

Breast Neoplasms, Carcinoma, Transitional Cell, Stomach Neoplasms

NCT04674306 2025-05-23

Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer

35 enrolled

Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT05464810 2025-05-23

Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer

40 enrolled

Anatomic Stage I Breast Cancer AJCC v8

NCT04648904 2025-05-22

Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer

71 enrolled

Invasive Breast Cancer

NCT03685175 2025-03-30

HPCardiotox

79 enrolled

Breast Neoplasms

NCT06637306 2025-03-26

Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer

15 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06756295 2025-03-12

FAST-CR

BreastDermatologicGastrointestinalThoracic

154 enrolled

Breast Neoplasms, Lung Neoplasms, Melanoma, Colorectal Neoplasms

NCT02872025 2025-01-30

Immunotherapy in High-risk Ductal Carcinoma in Situ (DCIS)

42 enrolled